Status:
COMPLETED
Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
Lead Sponsor:
Neosil, Inc.
Conditions:
Androgenetic Alopecia
Eligibility:
MALE
18-49 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to measure the hair growth response to topical NEOSH101 when applied twice daily to the balding scalp for 16 weeks. One hundred eighty men with Norwood/Hamilton grades III...
Eligibility Criteria
Inclusion
- Caucasian men, in general good health, aged 18-49 years
- Norwood/Hamilton grades III-IV, with thinning hair in the vertex area
Exclusion
- concomitant dermatologic or medical condition(s) which may interfere with the investigator's ability to evaluate the subject's response to the study drug
- treatment with a systemic or locally acting medication which may interfere with the study objectives, such as minoxidil treatment in the 6 months prior to study start, finasteride treatment in the 12 months prior to study start, or treatment with other investigational hair growth products in the 6 months prior to study start
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00418730
Start Date
January 1 2007
End Date
April 1 2008
Last Update
May 20 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
bioskin Institute for Dermatological Research and Development GmbH
Hamburg, Germany, 20095